Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-04.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
Tumor-to-tumor metastasis: metastatic invasive lobular carcinoma of the breast within adenocarcinoma of the lung

Tumor-to-tumor metastasis: metastatic invasive lobular carcinoma of the breast within adenocarcinoma of the lung

Article information

J Pathol Transl Med. 2020;54(2):188-191
Publication date (electronic) : 2019 September 16
doi : https://doi.org/10.4132/jptm.2019.09.07
Department of Pathology, Research Institute for Endocrine Sciences, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea
Corresponding Author: Kyoung Min Kim, MD, PhD Department of Pathology, Jeonbuk National University Medical School, 567 Baekjedaero, Deokjin-gu, Jeonju 54896, Korea Tel: +82-63-270-4691, Fax: +82-63-270-3135, E-mail: kmkim@jbnu.ac.kr
Received 2019 July 18; Revised 2019 August 30; Accepted 2019 September 7.

Tumor-to-tumor metastasis (TTM) is an extremely rare phenomenon in patients with multiple synchronous or metachronous primary malignancies. Previous studies reported that renal cell carcinoma and meningioma are the most common recipients of TTM, whereas the most prevalent donors are lung and breast carcinomas [1]. Although the lung is one of the organs most vulnerable to metastases, a lung carcinoma is one of the most rare recipients of TTM. To the best of our knowledge, only two cases of lung carcinoma harboring metastatic breast carcinoma have been reported in English literature [2]. Herein, we report another TTM case in which an invasive lobular carcinoma of the breast metastasized to a lung adenocarcinoma.

CASE REPORT

A 52-year-old woman’s medical check-up and ultrasonography revealed a 6.2-cm-sized mass in the right breast, which was diagnosed as invasive lobular carcinoma by needle biopsy. Before surgery, the patient underwent a full-body evaluation. Computed tomography revealed a mass in the right lung, which was diagnosed as pulmonary adenocarcinoma by needle biopsy (Fig. 1). Since the patient was suspected to have synchronous primary carcinomas in her lung and right breast with no sign of metastasis, she underwent right lower lobectomy for the lung adenocarcinoma and right mastectomy for the invasive lobular carcinoma of the right breast. The lung mass measured 2.3 cm in diameter. Microscopically, most of the lung mass exhibited typical growth patterns of lung adenocarcinoma. However, in one focus, the tumor cells showed a different arrangement and cytology; the tumor cells had minimal cytoplasm without nucleoli in a compact trabecular pattern. The typical adenocarcinoma cells were positive for thyroid transcription factor-1 (TTF-1) and E-cadherin and negative for estrogen and progesterone receptors. In contrast, tumor cells in the morphologically different focus expressed immunoreactivity for estrogen and progesterone receptors while they were negative for TTF-1 and E-cadherin (Fig. 2). Based on these findings, we concluded that the invasive lobular carcinoma of the patient’s right breast had metastasized to the lung adenocarcinoma. This study was approved by the Institutional Review Board of Jeonbuk National University Hospital with a waiver of informed consent (IRB No. 2019-05-027).

Fig. 1.

High resolution view of computed tomography scan shows pulmonary mass (arrow). The mass is located at right lower lobe of the lung and shows ground glass opacity.

Fig. 2.

Histologic features of the breast needle biopsy and resected lung mass. (A) The tumor cells of the breast mass are arranged in infiltrating single linear cords. (B) Scan view of the pulmonary mass shows dimorphic growth pattern (circular area vs. other region). (C) Higher magnification of the circular area of Fig. 2B. The tumor cells are arranged in compact trabecular pattern with minimal cytoplasm. (D) Other region of the lung mass showing typical acinar growth pattern. The tumor cells of the circular area of panel B are negative for thyroid transcription factor-1 (E) and E-cadherin (F) and positive for estrogen (G) and progesterone receptor (H).

DISCUSSION

TTM is an extremely rare phenomenon. Moreover, only approximately 180 cases have been reported in English literature. The most referenced and used criteria to diagnose TTM were proposed by Campbell et al. [3] as follows: (1) more than one primary tumor must be present; (2) the recipient tumor must be a true benign or malignant neoplasm; (3) the metastatic neoplasm must be a true metastasis with established growth in the host’s tumor, not the result of contiguous growth (‘collision tumor’) or embolization of tumor cells; and (4) tumors that have metastasized to the lymph nodes with existing lymphoreticular malignant tumors are excluded.

According to previous reports, renal cell carcinoma and meningioma are common recipient tumors of TTM (Table 1) [1]. They are both rich in vasculature and have high cytoplasmic lipid and glycogen content [4]. These conditions might be able to serve as a favorable microenvironment for disseminated cancer cells to metastasize. The lung is one of the most frequent sites of metastasis for extrathoracic malignancies. However, lung carcinomas are extremely rare to serve as a recipient tumor in a TTM phenomenon [1,2,5-7]. A possible explanation for this paradox is that lung carcinomas, when compared with normal lungs, are often accompanied by fibrosis and are lacking in the rich network of thin-walled vasculature [6,8]. Additionally, most lung carcinomas grow rapidly; therefore, they are less likely to provide enough nutrition for the immigrant cancer cells than renal cell carcinoma or meningioma [8].

Approximately estimated number of reported cases of tumor-to-tumor metastasis

A lung mass detected in a patient with a history of prior cancer proves to be a big challenge to clinicians, radiologists, and pathologists. Even worse, in TTM cases like our patient, it is nearly impossible for a radiologist to detect the metastatic lesion located inside the primary tumor. Besides, the needle biopsy, if not containing both primary and metastatic tumors of the mass, could be of no use. In our study, we interpreted the needle biopsy of the lung mass as a primary lung adenocarcinoma. Even after evaluation of the resection specimen, it is not an easy task to detect the metastasis whose focus is small and embedded in the recipient tumor. Therefore, if pathologists identify a histologically different focus in a morphologically typical primary lung tumor of a patient with two different primary cancers, they should always take TTM occurrence into consideration despite the slim chance.

In conclusion, we report a rare case of an invasive lobular carcinoma of the breast metastasizing to a lung adenocarcinoma. To avoid an incorrect diagnosis of a tumor with dimorphic appearance, the TTM phenomenon should be considered as a possibility. Moreover, it is of great importance to identify metastases because metastatic and non-metastatic tumors require different treatments.

Notes

Author contributions

Conceptualization: KMK, MJC.

Data curation: ARA, KMK.

Investigation: ARA, KMK.

Writing: MJK, KMK.

Conflicts of Interest

The authors declare that they have no potential conflicts of interest.

Funding

No funding to declare.

References

1. Petraki C, Vaslamatzis M, Argyrakos T, et al. Tumor to tumor metastasis: report of two cases and review of the literature. Int J Surg Pathol 2003;11:127–35.
2. Piacentini F, Rossi G, Casali C, Cadioli A, Barbieri E, Guarneri V. Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications. Lung Cancer 2011;74:145–8.
3. Campbell LV Jr, Gilbert E, Chamberlain CR Jr, Watne AL. Metastases of cancer to cancer. Cancer 1968;22:635–43.
4. Ortega P Jr, Li IY, Shimkin M. Metastasis of neoplasms to other neoplasms. Ann West Med Surg 1951;5:601–9.
5. Kim KM, Kim YN, Chu HH, Jin HY, Kim MH, Chung MJ. Papillary carcinoma of thyroid metastatic to adenocarcinoma in situ of lung: report of an unusual case. Korean J Pathol 2012;46:282–6.
6. Lee T, Cha YJ, Ahn S, Han J, Shim YM. A rare case of tumor-to-tumor metastasis of thyroid papillary carcinoma within a pulmonary adenocarcinoma. J Pathol Transl Med 2015;49:78–80.
7. Roscoe KJ, Raja S, Tronic B, Dou Y. Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer. Clin Nucl Med 2006;31:359–60.
8. Xue L, Luan Z, Liu Y, et al. Pulmonary metastasis of a papillary thyroid carcinoma and primary lung adenocarcinoma: two coincident carcinomas at the same location. Diagn Pathol 2013;8:26.

Article information Continued

Fig. 1.

High resolution view of computed tomography scan shows pulmonary mass (arrow). The mass is located at right lower lobe of the lung and shows ground glass opacity.

Fig. 2.

Histologic features of the breast needle biopsy and resected lung mass. (A) The tumor cells of the breast mass are arranged in infiltrating single linear cords. (B) Scan view of the pulmonary mass shows dimorphic growth pattern (circular area vs. other region). (C) Higher magnification of the circular area of Fig. 2B. The tumor cells are arranged in compact trabecular pattern with minimal cytoplasm. (D) Other region of the lung mass showing typical acinar growth pattern. The tumor cells of the circular area of panel B are negative for thyroid transcription factor-1 (E) and E-cadherin (F) and positive for estrogen (G) and progesterone receptor (H).

Table 1.

Approximately estimated number of reported cases of tumor-to-tumor metastasis

Recipient tumor Donor tumor No. of reported cases
Renal cell carcinoma Lung carcinoma 55
Breast carcinoma 6
Prostate carcinoma 4
Gastric carcinoma 2
Thyroid carcinoma 2
Colon carcinoma 2
Tonsil carcinoma 1
Melanoma 1
Rhabdomyosarcoma 1
Uterine cervix carcinoma 1
Meningioma Lung carcinoma 30
Breast carcinoma 13
Renal cell carcinoma 2
Gastric carcinoma 1
Melanoma 1
Thyroid cancer 1
Esophageal carcinoma 1
Thyroid neoplasm Renal cell carcinoma 10
Lung carcinoma 5
Colon carcinoma 2
Endometrial carcinoma 1
Breast carcinoma 1
Lung cancer Thyroid carcinoma 5
Breast carcinoma 2
Head and neck carcinoma 1
Colon carcinoma 1
Ovary neoplasm Uterine cervix carcinoma 1
Breast carcinoma 1
Appendix carcinoma 1
Colon carcinoma 1
Gastric carcinoma 1
Pituitary adenoma Breast carcinoma 1
Gastric carcinoma 1
Prostate carcinoma 1
Pancreatic endocrine neoplasm 1
Adrenocortical adenoma Lung carcinoma 2
Bladder carcinoma 1
Breast carcinoma 1
Pheochromocytoma Breast carcinoma 2
Renal cell carcinoma 1
Oligodendroglioma Colon carcinoma 1
Breast carcinoma 1
Melanoma 1
Prostate cancer Melanoma 1
Lung carcinoma 1
Thymic neoplasm Pancreatic carcinoma 1
Breast carcinoma 1